Cargando…

EZH2 contributes to 5-FU resistance in gastric cancer by epigenetically suppressing FBXO32 expression

BACKGROUND: Increasing evidence suggests the involvement of enhancer of zeste homologue 2 (EZH2) in chemoresistance of cancer treatment. Nevertheless, its function and molecular mechanisms in gastric cancer (GC) chemoresistance are still not well elucidated. MATERIALS AND METHODS: In the present stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chenyu, Li, Xingwang, Zhang, Junjie, Ge, Zheng, Chen, Hejin, Hu, Junhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225849/ https://www.ncbi.nlm.nih.gov/pubmed/30464532 http://dx.doi.org/10.2147/OTT.S180131

Ejemplares similares

EZH2 Contributes to 5-FU Resistance in Gastric Cancer by Epigenetically Suppressing FBXO32 Expression [Retraction]
Publicado: (2023)

FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells
por: Habel, Nadia, et al.
Publicado: (2021)

EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing miR-381 Expression
por: Dou, Dongwei, et al.
Publicado: (2019)

FBXO32, encoding a member of the SCF complex, is mutated in dilated cardiomyopathy
por: Al-Yacoub, Nadya, et al.
Publicado: (2016)

LINC-PINT suppresses cisplatin resistance in gastric cancer by inhibiting autophagy activation via epigenetic silencing of ATG5 by EZH2
por: Zhang, Cheng, et al.
Publicado: (2022)

RAI14 Promotes Melanoma Progression by Regulating the FBXO32/c-MYC Pathway
por: Xu, Jie, et al.
Publicado: (2022)

Promotive Effect of FBXO32 on the Odontoblastic Differentiation of Human Dental Pulp Stem Cells
por: Xu, Ke, et al.
Publicado: (2023)

Decreased FANCJ caused by 5FU contributes to the increased sensitivity to oxaliplatin in gastric cancer cells
por: Mori, Ryutaro, et al.
Publicado: (2012)

Aspirin suppresses chemoresistance and enhances antitumor activity of 5-Fu in 5-Fu-resistant colorectal cancer by abolishing 5-Fu-induced NF-κB activation
por: Fu, Jinbo, et al.
Publicado: (2019)

FBXO22, an epigenetic multiplayer coordinating senescence, hormone signaling, and metastasis
por: Johmura, Yoshikazu, et al.
Publicado: (2020)

RETRACTED ARTICLE: Inhibition of EZH2 enhances the therapeutic effect of 5-FU via PUMA upregulation in colorectal cancer
por: Tan, Xiao, et al.
Publicado: (2020)

Retraction Note: Inhibition of EZH2 enhances the therapeutic effect of 5-FU via PUMA upregulation in colorectal cancer
por: Tan, Xiao, et al.
Publicado: (2023)

Activated gastric cancer-associated fibroblasts contribute to the malignant phenotype and 5-FU resistance via paracrine action in gastric cancer
por: Ma, Yongchen, et al.
Publicado: (2018)

Mutation in FBXO32 causes dilated cardiomyopathy through up-regulation of ER-stress mediated apoptosis
por: Al-Yacoub, Nadya, et al.
Publicado: (2021)

5-FU Metabolism in Cancer and Orally-Administrable 5-FU Drugs
por: Miura, Koh, et al.
Publicado: (2010)

Long noncoding RNA LINC00673 epigenetically suppresses KLF4 by interacting with EZH2 and DNMT1 in gastric cancer
por: Ba, Ming-Chen, et al.
Publicado: (2017)

Long noncoding RNA SNHG6 silencing sensitized esophageal cancer cells to 5-FU via EZH2/STAT pathway
por: Tan, Ran, et al.
Publicado: (2023)

Epigenetic Mechanism of Enrichment of A549 Lung Cancer Stem Cells with 5-Fu
por: Cao, Fangyuan, et al.
Publicado: (2021)

MYCN contributes to the malignant characteristics of erythroleukemia through EZH2-mediated epigenetic repression of p21
por: Liu, Li, et al.
Publicado: (2017)

A substitution mutation in cardiac ubiquitin ligase, FBXO32, is associated with an autosomal recessive form of dilated cardiomyopathy
por: Al-Hassnan, Zuhair N., et al.
Publicado: (2016)

miR-19a-3p Functions as an Oncogene by Regulating FBXO32 Expression in Multiple Myeloma
por: Li, Ying, et al.
Publicado: (2021)

LINC00494 Promotes Ovarian Cancer Development and Progression by Modulating NFκB1 and FBXO32
por: Shu, Yang, et al.
Publicado: (2021)

The FBXO32/ATR/ATM axis acts as a molecular switch to control the sensitivity of osteosarcoma cells to irradiation through its regulation of EXO1 expression: FBXO32/ATR/ATM/EXO1 axis induces OS cells to anti-radiotherapy
por: Lu, Yao, et al.
Publicado: (2023)

Targeting EZH1 and EZH2 contributes to the suppression of fibrosis-associated genes by miR-214-3p in cardiac myofibroblasts
por: Zhu, Wen-Si, et al.
Publicado: (2016)

Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines
por: Suetsugu, Tomonari, et al.
Publicado: (2021)

MiR-32 Inhibits Proliferation and Metastasis by Targeting EZH2 in Glioma
por: Zhang, Yuan, et al.
Publicado: (2019)

FBXO5 acts as a novel prognostic biomarker for patients with cervical cancer
por: Jiang, Shan, et al.
Publicado: (2023)

FBXO22 degrades nuclear PTEN to promote tumorigenesis
por: Ge, Meng-Kai, et al.
Publicado: (2020)

Epigenetic repression of the Igk locus by STAT5-mediated Ezh2 recruitment
por: Mandal, Malay, et al.
Publicado: (2011)

Circular RNA circ_0006282 Contributes to the Progression of Gastric Cancer by Sponging miR-155 to Upregulate the Expression of FBXO22
por: He, Yiren, et al.
Publicado: (2020)

A novel likely pathogenic variant in the FBXO32 gene associated with dilated cardiomyopathy according to whole‑exome sequencing
por: Ghasemi, Serwa, et al.
Publicado: (2022)

Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF)
por: Sadighi, Sanambar, et al.
Publicado: (2006)

LncRNA FBXO18-AS promotes gastric cancer progression by TGF-β1/Smad signaling
por: Zhang, Yiming, et al.
Publicado: (2023)

Advanced glycation end products impair coronary artery BK channels via AMPK/Akt/FBXO32 signaling pathway
por: Li, Xiao-Yan, et al.
Publicado: (2023)

Targeting epigenetics in sarcomas through EZH2 inhibition
por: Italiano, Antoine
Publicado: (2020)

Preliminary Study of the Role F-Box Protein 32 (FBXO32) in Colorectal Neoplasms Through the Transforming Growth Factor beta (TGF-β)/Smad4 Signalling Pathway
por: Yuan, Xuemin, et al.
Publicado: (2018)

Emerging role of FBXO22 in carcinogenesis
por: Cheng, Jiangting, et al.
Publicado: (2020)

EZH2: An Accomplice of Gastric Cancer
por: Yu, Wuhan, et al.
Publicado: (2023)

Over-expression of EGFR regulated by RARA contributes to 5-FU resistance in colon cancer
por: Gu, Xin-Yue, et al.
Publicado: (2020)

FBXO28 suppresses liver cancer invasion and metastasis by promoting PKA-dependent SNAI2 degradation
por: Qiao, Xinran, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0tmui954ilrfl2erjs0cklfb0n